These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2339692)

  • 21. Brain cDNA clone for human cholinesterase.
    McTiernan C; Adkins S; Chatonnet A; Vaughan TA; Bartels CF; Kott M; Rosenberry TL; La Du BN; Lockridge O
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6682-6. PubMed ID: 3477799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsense mutation in exon 2 of the butyrylcholinesterase gene: a case of familial cholinesterasemia.
    Hidaka K; Iuchi I; Yamasaki T; Ueda N; Hukano K
    Clin Chim Acta; 1997 May; 261(1):27-34. PubMed ID: 9187502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of the silent gene for plasma cholinesterase. Immunological studies.
    Whittaker M; Jones J; Braven J
    Hum Hered; 1990; 40(3):153-8. PubMed ID: 2365375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic basis of the silent phenotype of serum butyrylcholinesterase in three compound heterozygotes.
    Maekawa M; Sudo K; Kanno T; Kotani K; Dey DC; Ishikawa J; Izumi M; Etoh K
    Clin Chim Acta; 1995 Feb; 235(1):41-57. PubMed ID: 7634491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site.
    Jensen FS; Nielsen LR; Schwartz M
    Hum Hered; 1996; 46(1):26-31. PubMed ID: 8825459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal enzyme phenotype (E1a E1f): normal response to succinylcholine.
    McQueen MJ; Lepinskie F; Strickland RD; Trimble A
    Can Anaesth Soc J; 1979 Mar; 26(2):99-103. PubMed ID: 466558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Succinylcholine sensitivity in a Nova Scotia family.
    Candy JJ; McQueen MJ
    Can Anaesth Soc J; 1978 Jan; 25(1):53-9. PubMed ID: 624106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Presentation of a case of a silent genetic cholinesterase variant].
    Carrasco MS; Gómez Armenta F; Gil C; de Ory MJ; Bolinches R; Pastor J; Andreu L
    Rev Esp Anestesiol Reanim; 1985; 32(4):184-6. PubMed ID: 4048582
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone.
    Prody C; Zevin-Sonkin D; Gnatt A; Koch R; Zisling R; Goldberg O; Soreq H
    J Neurosci Res; 1986; 16(1):25-35. PubMed ID: 3755763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged apnoea after suxamethonium in a Malaysian patient due to silent plasma cholinesterase--first case report.
    Mohandas K; Sivaneswaran N
    Med J Malaysia; 1982 Jun; 37(2):157-9. PubMed ID: 7132835
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of serum cholinesterase in succinylcholine apnoea.
    Scholler KL; Goedde HW; Benkmann HG
    Can Anaesth Soc J; 1977 May; 24(3):396-400. PubMed ID: 871943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of cholinesterase activity in the population of Trinidad.
    Pinto Pereira LM; Clement Y; Telang BV
    Can J Physiol Pharmacol; 1996 Mar; 74(3):286-9. PubMed ID: 8773408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase.
    Neville LF; Gnatt A; Loewenstein Y; Soreq H
    J Neurosci Res; 1990 Dec; 27(4):452-60. PubMed ID: 2079709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of ABO glycosyltransferase genotypes by use of polymerase chain reaction and restriction enzymes.
    Stroncek DF; Konz R; Clay ME; Houchins JP; McCullough J
    Transfusion; 1995 Mar; 35(3):231-40. PubMed ID: 7878716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological studies of families segregating the silent gene for plasma cholinesterase.
    Whittaker M; Jones JW; Braven J
    Hum Hered; 1991; 41(2):77-83. PubMed ID: 1855785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA.
    Andersen BD; Lind B; Philips M; Hansen AB; Ingerslev J; Thorsen S
    Thromb Haemost; 1996 Aug; 76(2):143-50. PubMed ID: 8865520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inheritance of low plasma cholinesterase activity in two families with a history of suxamethonium sensitivity.
    Whittaker M; Berry M; Britten JJ
    Anaesthesia; 1989 Jun; 44(6):480-2. PubMed ID: 2757153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 40. [A family of pseudocholinesterase deficiency (silent type II)].
    Yokota H; Toyota S; Ohkubo S; Kamei S; Uchimura H; Okubo A; Houzumi M; Sudo K; Sakamoto Y
    Rinsho Byori; 1989 Oct; 37(10):1177-80. PubMed ID: 2601076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.